Savings of up to 50% offered to help upskill workforces in the pharma, biotech and medical device sectors

Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is now providing up to 50% concession per learner per course. Following its recent introduction of innovative game-based e-learning modules, PTI is providing the opportunity to make substantial savings on its full range of training courses to start-ups and SMEs (with fewer than 50 employees), as well as non-profit organisations and government bodies. This reduces the financial implications for organisations, especially those in the early stages of growth, allowing staff to gain access to the training they need.

With courses designed for organisations of all sizes, PTI provides public, tailored on-site and distance learning courses with expert, experienced instructors, dedicated to delivering high calibre training. Courses cover a range of topics in the (bio)pharma, medical devices and diagnostics areas which include business strategy, clinical trials, manufacturing, R&D and regulatory affairs. PTI has recently further enhanced its popular e-learning courses by being the first company to bring innovative game-based learning to the life sciences, an approach already used successfully in other sectors.

The new game-based e-learning modules provide an engaging, entertaining and cost-saving method of acquiring new skills. They are a continuation of PTI’s trend of delivering a unique blend of interactive learning tools that now includes a 3D virtual interactive environment. Using this, ‘players’ are able to role-play scenarios, gaining realistic, practical experience through a virtual medium at a lower cost compared to face-to-face training. A demonstration video of PTI’s 3D virtual interactive e-learning environment is available to view online.

PTI’s Managing Director, Rosie Bernard, commented: “PTI provides the very best training to support organisations involved in the pharmaceutical and medical device sectors. We are delighted to be able to offer substantial savings of up to 50% to new and growing companies, as well as non-profit organisations and governmental bodies, and hope this approach allows more life science professionals to increase their skills by taking advantage of our industry-recognised training courses.”

more about PTI